AbbVie
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $14,460,000 | $14,462,000 | $12,310,000 | $14,301,000 |
Gross Profit | 10,248,000 | 12,286,000 | 8,228,000 | 11,915,000 |
EBITDA | 4,933,000 | 7,129,000 | 5,557,000 | 6,625,000 |
EBIT | 2,854,000 | 4,998,000 | 3,483,000 | 4,549,000 |
Net Income | 1,561,000 | 1,370,000 | 1,369,000 | 822,000 |
Net Change In Cash | 14,460,000 | 14,462,000 | 12,310,000 | 14,301,000 |
Free Cash Flow | 5,198,000 | 2,030,000 | 3,847,000 | 4,548,000 |
Cash | 7,257,000 | 13,130,000 | 18,067,000 | 12,814,000 |
Basic Shares | 1,772,000 | 1,771,000 | 1,773,000 | 1,772,000 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $54,318,000 | $58,054,000 | $56,197,000 | $45,804,000 |
Gross Profit | 33,903,000 | 40,640,000 | 38,751,000 | 30,417,000 |
EBITDA | 17,308,000 | 31,424,000 | 28,280,000 | 21,148,000 |
EBIT | 8,610,000 | 22,957,000 | 19,759,000 | 14,677,000 |
Net Income | 4,863,000 | 11,836,000 | 11,542,000 | 4,616,000 |
Net Change In Cash | 54,318,000 | 58,054,000 | 56,197,000 | 45,804,000 |
Cost of Revenue | -483,000 | 1,297,000 | -31,475,000 | |
Free Cash Flow | 22,062,000 | 24,248,000 | 21,990,000 | 16,790,000 |
Cash | 12,814,000 | 9,201,000 | 9,746,000 | 8,449,000 |
Basic Shares | 1,773,000 | 1,778,000 | 1,777,000 | 1,673,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $3 |
2024-06-30 | $2.65 |
2024-03-31 | $2.31 |
2023-12-31 | $2.79 |
